The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 509.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.196%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

4 Oct 2016 12:46

RNS Number : 6499L
Babcock International Group PLC
04 October 2016
 

Babcock International Group PLC ("Babcock" or "the Group")

4 October 2016

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 3 October 2016 (the "Final Terms") relating to the issue by Babcock on 5 October 2016 of GBP 250,000,000 1.875 per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 19 September 2016 (the "Base Prospectus") relating to the £1,800,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6499L_-2016-10-4.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Kate Hill - Head of Investor Relations

Babcock International Group PLC

Address: 33 Wigmore Street, London W1U 1QX

 

Telephone: +44 207 355 5314

 

Email: kate.hill@babcockinternational.com

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Final Terms whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Final Terms shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Final Terms have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTFZLFBQBFZFBZ
Date   Source Headline
19th Sep 20187:00 amRNSTrading Update
7th Sep 201810:35 amRNSPublication of a Prospectus
14th Aug 20183:04 pmRNSDirector/PDMR Shareholding
3rd Aug 20189:47 amRNSDirector/PDMR Shareholding
30th Jul 20187:00 amRNSStatement re: article in The Sunday Times
24th Jul 201810:35 amRNSDirector/PDMR Shareholding
20th Jul 201810:41 amRNSDirector/PDMR Shareholding
20th Jul 201810:40 amRNSDirector/PDMR Shareholding
20th Jul 201810:37 amRNSDirector/PDMR Shareholding
19th Jul 20181:00 pmRNSResult of AGM
19th Jul 20187:00 amRNSAnnual General Meeting Trading Update
29th Jun 201810:14 amRNSHolding(s) in Company
15th Jun 20189:37 amRNSHolding(s) in Company
14th Jun 20185:48 pmRNSDirector/PDMR Shareholding
14th Jun 20184:30 pmRNSNotice of AGM
14th Jun 201810:42 amRNSDirector/PDMR Shareholding
31st May 201810:00 amRNSContract Extension
23rd May 20187:00 amRNSFinal Results
10th May 20189:47 amRNSHolding(s) in Company
24th Apr 20189:56 amRNSHolding(s) in Company
27th Mar 201811:26 amRNSDirector/PDMR Shareholding
23rd Mar 20188:37 amRNSDirector Declaration
14th Mar 20184:18 pmRNSHolding(s) in Company
12th Mar 20188:53 amRNSDirector/PDMR Shareholding
9th Mar 20188:56 amRNSDirector/PDMR Shareholding
16th Feb 201812:46 pmRNSHolding(s) in Company
15th Feb 201812:34 pmRNSHolding(s) in Company
15th Feb 201812:32 pmRNSHolding(s) in Company
6th Feb 20187:00 amRNSTrading Update
19th Jan 20184:57 pmRNSHolding(s) in Company
19th Jan 20182:08 pmRNSHolding(s) in Company
18th Jan 20189:00 amRNSBabcock awarded Italian firefighting contract
17th Jan 20184:56 pmRNSDirector/PDMR Shareholding
12th Jan 20189:39 amRNSHolding(s) in Company
10th Jan 201810:19 amRNSHolding(s) in Company
8th Jan 20187:00 amRNSBabcock launches 'Team 31' bid for new UK frigate
3rd Jan 20187:00 amRNSBabcock signs agreement with Australian Navy
21st Dec 20177:00 amRNSDirectorate Change
18th Dec 20177:00 amRNSContract Award
11th Dec 20177:00 amRNSStatement re: Adoption of IFRS 15
6th Dec 201712:50 pmRNSDirector/PDMR Shareholding
30th Nov 20174:23 pmRNSDirector Declaration
29th Nov 201711:18 amRNSDirector/PDMR Shareholding
27th Nov 20172:10 pmRNSDirector/PDMR Shareholding
27th Nov 20172:05 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
16th Nov 20172:00 pmRNSContract Award
16th Oct 20178:28 amPRNNet Asset Value(s)
6th Oct 20172:42 pmRNSAnna Stewart
20th Sep 20179:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.